Dr. Susan L. Cohn
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Neuroblastoma
Expert in Tumors
19 reported clinical trials
38 drugs studied
Area of expertise
1Neuroblastoma
Global LeaderStage IV
MYC positive
MYC negative
2Tumors
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Susan L. Cohn is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
More about Susan L. Cohn
Clinical Trial Related7 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Susan L. Cohn has experience with
- Carboplatin
- Etoposide
- Cyclophosphamide
- Laboratory Biomarker Analysis
- Erdafitinib
- Olaparib
Breakdown of trials Susan L. Cohn has run
Neuroblastoma
Tumors
Brain Tumor
Germ Cell Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan L. Cohn specialize in?
Susan L. Cohn focuses on Neuroblastoma and Tumors. In particular, much of their work with Neuroblastoma has involved Stage IV patients, or patients who are MYC positive.
Is Susan L. Cohn currently recruiting for clinical trials?
Yes, Susan L. Cohn is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Susan L. Cohn has studied deeply?
Yes, Susan L. Cohn has studied treatments such as Carboplatin, Etoposide, Cyclophosphamide.
What is the best way to schedule an appointment with Susan L. Cohn?
Apply for one of the trials that Susan L. Cohn is conducting.
What is the office address of Susan L. Cohn?
The office of Susan L. Cohn is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.